Fluconazole versus amphotericin B in the treatment of esophageal candidiasis in cancer patients

Chemotherapy

Volumn 42, Issue 4, 1996, Pages 308-314

  Lake, D E E ^a   Kumweiler, J ^a   Beer, M ^a   Buell, D N ^a   Islam, M Z ^a  

^a ST MICHAEL S MEDICAL CENTER   (United States)

Author keywords

Amphotericin; Candidiasis; Compromised host; Esophagitis; Fluconazole

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER; CANDIDIASIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DYSPHAGIA; ESOPHAGITIS; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; FEMALE; FEVER; FUNGUS CULTURE; HUMAN; HYPOMAGNESEMIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PHLEBITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RIGOR; SCHOOL CHILD; SWEATING; TACHYCARDIA; VOMITING;

EID: 0030004665     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000239459     Document Type: Article

References (23)

1. Bodey GP: The emergence of fungi as major hospital pathogens. J Hosp Infect 1988;11:411-426.
2. Bodey GP: Candidiasis in cancer patients. Am J Med 1984;77:13-19.
3. Bodey GP, Samonis G, Rolston K: Prophylaxis of candidiasis in cancer patients. Semin Oncol 1990; 17(suppl 6):24-28.
4. Eras P, Goldstein MJ, Sherlock P: Candida infection of the gastrointestinal tract. Medicine 1972;51:367-379.
5. Walsh J, Merz MG: Pathological features in the human alimentary tract associated with invasiveness of Candida tropicalis. Am J Clin Pathol 1986;85:498-502.
6. Walsh TJ, Hamilton SR, Belitros N: Esophageal candidiasis. Postgrad Med 1988;84:193-205.
7. Sande MA, Mandell GL: Miscellaneous antibacterial agents: Antifun-gal and antiviral agents; in Gilman AG, Goodman LS, Gilman A (eds): The Pharmacological Basis of Therapeutics, ed 6. New York, Macmillan, 1980, pp 1222-1248.
8. Butler WT, Bennett JE, Alling DW, Wertlake PT, Utz JP, Hill GJ: Nephrotoxicity of amphotericin B: Early and late effects in 81 patients. Ann Intern Med 1964;61:175-187.
9. Medoff G, Kobayashi GS: Strategies in the treatment of systemic fungal infections. N Engl J Med 1980;302: 145-155.
10. Dismukes WE: Azole antifungal drugs: Old and new. Ann Intern Med 1988;109:177-179.
11. Saag MS, Dismukes WE: Azoic antifungal agents: Emphasis on the new triazoles. Antimicrob Agents Che-mother 1988;32:1-8.
12. Brammer KW, Tarbit MH: A review of the pharmacokinetics of fluconazole (UK-49.858) in laboratory animals and man; in Fromtling RA (ed): Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents. Paris, Prous, 1987, pp 141-149.
13. Milliken S, Helenglass G, Powles R: Fluconazole pharmacokinetics following oral dosage in leukaemic patients receiving autologous bone marrow transplantation. Bone Marrow Transplant 1980;3:324-325.
14. Gil A, Lavilla P, Valencia E, Pintado V, Dupla ML, Khamashia MA: Safety and efficacy of fluconazole treatment for Candida esophagitis in AIDS. Postgrad Med J 1991;67: 548-552.
15. DeWit S, Urbain D, Rahir F, Weerts D, Clumeck N: Efficacy of oral fluconazole in the treatment of AIDS associated with esophageal candidiasis. Eur J Clin Microbiol Infect Dis 1991;10:503-505.
16. Lake-Bakaar G, Tom W, Lake-Ba-kaar D, Gupta N, Bcidas S, Elsakr M: Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome. Ann Intern Med 1988;109:471-473.
17. Fazio RA, Wickremesinghe PC, As-ura EL: Ketoconazole treatment of Candida esophagitis: A prospective study of 12 cases. Am J Gastroenterol 1983;78:261-264.
18. Tavitian A, Raufman JP, Rosenthal LE, Weber J, Weber CA, Dinçsoy HP: Ketoconazole resistant Candida esophagitis in patients with acquired immunodeficiency syndrome. Gastroenterology 1986;90: 443-445.
19. Dixon WJ (ed): BMDP Statistical Software Manual. Los Angeles, University of California Press. 1992; 135-174,245-328.
20. Dixon WJ, Massey FJ Jr: Introduction to Statistical Analysis, ed 4. New York, McGraw-Hill, 1983.
21. Machin D, Campbell MJ (eds): Sta-tisticalTablesforthe Design ofClinical Trials. Oxford, Blackwell, 1987, pp 10-34,79-88.
22. Engelhard D, Stutman HR, Marks MI: Interaction of ketoconazole with rifampin and isoniazid. N Engl J Med 1984;311:1681-1683.
23. Dieperink H, Moller J: Ketoconazole and cyclosporin (letter). Lancet 1982;ii:217.